@article {1688,
	title = {Initial Experience with Repetitive Transarterial Chemoembolization (TACE) as a Third Line Treatment of Ovarian Cancer Metastasis to the Liver: Indications, Outcomes and Role in Patient{\textquoteright}s Management},
	journal = {Physical Review Letters},
	year = {2012},
	note = {n/a},
	abstract = {<p>Objective: To evaluate local tumor control and survival data after transarterial chemoembolization (TACE) with different drug combinations in the palliative third-line treatment of patients with ovarian cancer liver metastases.Methods: Sixty-five patients (mean age: 51.5 year) with unresectable hematogenous hepatic metastases of ovarian cancer who did not respond to systemic chemotherapy were repeatedly treated with TACE in 4-week intervals. The local chemotherapy protocol consisted of Mitomycin (group 1) (n=14; 21.5\%),</p>
},
	author = {Thomas J Vogl and Nagy NN Naguib and Thomas Lehner and A. Nour-Eldin and Katrin Eichler and Stephan Zangos and Tatjana}
}
